Momenta Pharmaceuticals to Webcast Presentation at the 34th Annual J. P. Morgan Healthcare Conference
January 05 2016 - 8:00AM
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, today announced that Craig Wheeler, President and
CEO, will present at the 34th Annual J. P. Morgan Healthcare
Conference. The presentation will be webcast on Wednesday,
January 13th at 10:30 a.m. ET.
Following the presentation, management will
participate in a question and answer session at 11:00 a.m. ET.
The audio webcast of the presentation and
Q&A session will be available live on the “Investors” section
of the company’s website located at www.momentapharma.com. A
replay of the presentation will be posted on the Momenta website
approximately one hour after the event and will be available for
two weeks following the presentation.
About MomentaMomenta
Pharmaceuticals is a biotechnology company specializing in the
detailed structural analysis of complex drugs and is headquartered
in Cambridge, MA. Momenta is applying its technology to
the development of generic versions of complex drugs, biosimilar
and potentially interchangeable biologics, and to the discovery and
development of novel therapeutics for oncology and autoimmune
indications.
To receive additional information about Momenta,
please visit the website at www.momentapharma.com, which does
not form a part of this press release.
Our logo, trademarks, and service marks are the
property of Momenta Pharmaceuticals, Inc. All other trade names,
trademarks, or service marks are property of their respective
owners.
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024